Drugs / Lactomin
last change May 2020 re-read 3 minutes ago

Lactomin

Developed for
pneumatosis cystoides intestinalis
Investigated by
Showa Inan General Hospital

Trials 1

2021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT04368663 May 2020 → Dec 2026 expected pneumatosis cystoides intestinalis Showa Inan General Hospital Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as lactomin “TJ-134 (7.5g/day) or lactomin (3g/day) is administered for 8 weeks.” NCT04368663 ↗
1

“Lactomin (3g/day) is administered to enrolled patients for 8 weeks.” NCT04368663 ↗